WILMINGTON, N.C., Dec. 12, 2012 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.
During his 20 year career at AAIPharma, Dr. Shirazi has helped AAIPharma excel in analytical chemistry and product development, most recently as vice president of analytical development. With over 50 publications in scientific journals and a reference book in chromatography ("Fundamentals of Preparative and Nonlinear Chromatography, Second Edition"), Dr. Shirazi is a recognized expert in multiple types of liquid chromatography and gas chromatography. Throughout his tenure, he has hired and trained a significant portion of laboratory personnel at AAIPharma, helping AAIPharma establish its leadership position in analytical chemistry and drug development. In his new role, Dr. Shirazi will have responsibilities over the Wilmington and Durham analytical laboratories.
"At AAIPharma, it has been an honor to work with thousands of clients throughout the industry," said Dr. Shirazi. "My team and I look forward to continuing to help clients with their unique analytical challenges."
"The tenured analytical teams have long been the cornerstone of AAIPharma," said Patrick Walsh, Chief Executive Officer. "As we continue to add new analytical capabilities in our new Wilmington Technology Center, Dr. Shirazi's analytical and regulatory expertise continues to be instrumental in coordinating our growth strategy."
Dr. Shirazi received his doctorate in analytical chemistry from Georgetown University. He conducted post-doctoral research at the University of Tennessee as a research associate, and his areas of interest are high performance liquid chromatography (HPLC), gas chromatography (GC), preparative chromatography, chiral separation and optimization of experimental conditions in chromatography.
About AAIPharma Services Corp.
AAIPharma Services Corp. is a leading provider of contract services that support all phases of drug development. The company's wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, clinical and commercial contract manufacturing, pharmaceutical packaging and stability services. Serving more than 600 clients around the globe and headquartered in Wilmington, N.C., AAIPharma is a portfolio company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.
For more information on the company, visit:
For more information about our analytical development services, visit:
For more information about our analytical testing services, visit:
SOURCE AAIPharma Services Corp.